REDWOOD CITY, Calif., July 21, 2025 /PRNewswire/ -- Synthego, a leading provider of CRISPR solutions, today announced the successful closing of the acquisition of substantially all of its assets by ...

REDWOOD CITY, Calif., April 8, 2025 /PRNewswire/ -- Synthego and Vita Therapeutics, Inc. today announced a licensing agreement to integrate Synthego's high-fidelity hfCas12Max CRISPR system into ...

We hear a lot about the potential and implications of the gene-editing technique CRISPR, but it’s not like just anyone can open up an app, pick a gene they don’t like, and build the molecular ...

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Synthego, the genome engineering company, announced today that the company has broken ground on a 20,000-square-foot manufacturing facility designed to ...

Paul Dabrowski, the chief executive officer of Synthego, which provides genetically engineered cells to scientists and researchers, worries about a future where access to the genetic technologies that ...

REDWOOD CITY, Calif., October 15, 2020 - Synthego, the genome engineering company, has collaborated with The Krogan Lab, a world-renowned scientific research unit at the Quantitative Biosciences ...

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Synthego, the genome engineering company, today announced the launch of Engineered Cell Libraries, a novel offering that further enables access to CRISPR by ...

Synthego to develop multiplexed and complex genetic engineering strategies, increasing the safety and speed at which bit.bio can engineer human cells for cell therapies. bit.bio aims to leverage ...

Join our daily and weekly newsletters for the latest updates and exclusive content on industry-leading AI coverage. Learn More Synthego, which is developing a machine learning-based approach to ...

The Nature Index tracks primary research articles from 178 applied, health, natural and social sciences journals, across many different publishers, chosen by an independent group of researchers. The ...